These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
846 related articles for article (PubMed ID: 29642926)
1. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism. Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926 [TBL] [Abstract][Full Text] [Related]
2. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy. Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208 [TBL] [Abstract][Full Text] [Related]
3. Impact of P2RX7 ablation on the morphological, mechanical and tissue properties of bones in a murine model of duchenne muscular dystrophy. Mohamad NS; Sinadinos A; Górecki DC; Zioupos P; Tong J J Biomech; 2016 Oct; 49(14):3444-3451. PubMed ID: 27663621 [TBL] [Abstract][Full Text] [Related]
4. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy. Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042 [TBL] [Abstract][Full Text] [Related]
5. A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90. Young CN; Sinadinos A; Lefebvre A; Chan P; Arkle S; Vaudry D; Gorecki DC Autophagy; 2015; 11(1):113-30. PubMed ID: 25700737 [TBL] [Abstract][Full Text] [Related]
6. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy. Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419 [TBL] [Abstract][Full Text] [Related]
7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
8. Dystrophin: The dead calm of a dogma. Górecki DC Rare Dis; 2016; 4(1):e1153777. PubMed ID: 27141413 [TBL] [Abstract][Full Text] [Related]
9. Investigating the Involvement of C-X-C Motif Chemokine 5 and P2X7 Purinoceptor in Ectopic Calcification in Mouse Models of Duchenne Muscular Dystrophy. Rumney RMH; Pomeroy J; Górecki DC J Cell Biochem; 2024 Aug; 125(8):e30617. PubMed ID: 38924558 [TBL] [Abstract][Full Text] [Related]
10. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069 [TBL] [Abstract][Full Text] [Related]
11. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy. Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840 [TBL] [Abstract][Full Text] [Related]
13. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Rooney JE; Gurpur PB; Burkin DJ Proc Natl Acad Sci U S A; 2009 May; 106(19):7991-6. PubMed ID: 19416897 [TBL] [Abstract][Full Text] [Related]
14. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models. Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448 [TBL] [Abstract][Full Text] [Related]
15. The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies. Zabłocki K; Górecki DC Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298386 [TBL] [Abstract][Full Text] [Related]
16. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy. Ito M; Ehara Y; Li J; Inada K; Ohno K Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975 [TBL] [Abstract][Full Text] [Related]
17. Lipocalin 2 Influences Bone and Muscle Phenotype in the Ponzetti M; Ucci A; Maurizi A; Giacchi L; Teti A; Rucci N Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055145 [TBL] [Abstract][Full Text] [Related]